RXST R&D to Revenue
Rxsight Inc · R&D to Revenue
RXST R&D to Revenue
Latest reported27.38%period ending
RXST Quarterly R&D/Revenue (200.03% → 27.38%)
Latest values, visible window
High-resolution chart · PNG
RXST r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 27.3762% | |
| 30.6607% | |
| 27.3101% | |
| 29.8616% | |
| 30.3743% | |
| 27.3572% | |
| 22.895% | |
| 19.4635% | |
| 23.7653% | |
| 27.2127% | |
| 25.6858% | |
| 23.1552% | |
| 35.5646% | |
| 41.2145% | |
| 41.5278% | |
| 50.6381% | |
| 54.507% | |
| 75.1398% | |
| 70.2113% | |
| 92.9312% | |
| 134.0208% | |
| 190.6716% | |
| 107.2853% | |
| 139.1127% | |
| 187.8788% | |
| 200.0346% |